The Claim
The μ-opioid receptor antagonist cyprodime completely blocks β-casomorphin-7-induced mucin secretion and gene expression in both rat and human intestinal cell lines, confirming that the effect is mediated specifically through μ-opioid receptor activation and not off-target pathways.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Cyprodime, a drug that blocks μ-opioid receptors, prevents β-casomorphin-7 from triggering mucin secretion and related gene activity in intestinal cells from rats and humans.
See the scientific wording
The μ-opioid receptor antagonist cyprodime completely blocks β-casomorphin-7-induced mucin secretion and gene expression in both rat and human intestinal cell lines, confirming that the effect is mediated specifically through μ-opioid receptor activation and not off-target pathways.
A milk-derived peptide binds to a specific receptor on mucus-producing cells in the gut, turning on genes that make mucus proteins and causing those proteins to be released, and blocking that receptor stops the entire process.
What the research says
1 studyWhen scientists blocked a specific receptor (μ-opioid) in gut cells, the milk peptide β-casomorphin-7 could no longer make more mucus — proving it only works through that one receptor, not by accident.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.